| Comparative stability studies of different infliximab and biosimilar CT-P13 clinical solutions by combined use of physicochemical analytical techniques and enzyme-linked … J Hermosilla, R Sánchez-Martín, R Pérez-Robles, A Salmerón-García, ... BioDrugs 33, 193-205, 2019 | 20 | 2019 |
| Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation J Hermosilla, R Pérez-Robles, A Salmerón-García, S Casares, J Cabeza, ... Scientific Reports 10 (1), 2675, 2020 | 19 | 2020 |
| The relevance of monoclonal antibodies in the treatment of COVID-19 A Torrente-López, J Hermosilla, N Navas, L Cuadros-Rodríguez, ... Vaccines 9 (6), 557, 2021 | 13 | 2021 |
| Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes N Navas, J Hermosilla, A Torrente-López, J Hernández-Jiménez, ... Journal of Pharmaceutical Analysis 10 (6), 532-545, 2020 | 11 | 2020 |
| Comprehensive analysis of Nivolumab, A therapeutic anti-Pd-1 Monoclonal antibody: Impact of handling and stress A Torrente-López, J Hermosilla, A Salmerón-García, J Cabeza, N Navas Pharmaceutics 14 (4), 692, 2022 | 7 | 2022 |
| Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies J Hermosilla, R Pérez-Robles, A Salmerón-García, S Casares, J Cabeza, ... Journal of Pharmaceutical and Biomedical Analysis 203, 114209, 2021 | 4 | 2021 |
| Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™(Pfizer) and Spikevax™(Moderna): A Comparative Study of the Particulate J Hermosilla, A Alonso-García, A Salmerón-García, J Cabeza-Barrera, ... Vaccines 11 (11), 1635, 2023 | 3 | 2023 |
| Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing R Pérez-Robles, A Salmerón-García, J Hermosilla, A Torrente-López, ... European Journal of Pharmaceutics and Biopharmaceutics 184, 103-115, 2023 | 2 | 2023 |
| Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen–antibody binding A Torrente-López, J Hermosilla, A Salmerón-García, J Cabeza, ... European Journal of Pharmaceutics and Biopharmaceutics 194, 131-147, 2024 | 1 | 2024 |
| Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers R Pérez-Robles, J Hermosilla, N Navas, S Clemente-Bautista, ... Journal of Pharmaceutical and Biomedical Analysis 221, 115064, 2022 | 1 | 2022 |
| 3PC-009 The effect of accelerated light (stress) and natural sunlight exposures on cetuximab (Erbitux®): evaluation of aggregate formation and functionality A Torres-García, A Torrente-López, J Hermosilla, A Aguilera-Ortega, ... European Journal of Hospital Pharmacy 31 (Suppl 1), A32-A33, 2024 | | 2024 |
| 3PC-017 Impact of agitation on pembrolizumab (Keytruda®) safety and efficacy: aggregation and functionality A Torrente-López, R Pérez-Robles, J Hermosilla, J Ruiz-Travé, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A18-A18, 2023 | | 2023 |
| 5PSQ-067 Tracking the overal in use and stress stability of romiplistim (n-plate®) by the evaluation of a selected set of critical quality attributes R Pérez-Robles, J Ruiz-Travé, M Martinez, J Hermosilla, ... European Journal of Hospital Pharmacy 30 (Suppl 1), A135-A135, 2023 | | 2023 |
| Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab A Torrente-López, J Hermosilla, R Pérez-Robles, A Salmeron-Garcia, ... Microchemical Journal 182, 107896, 2022 | | 2022 |
| 3PC-045 Impact of the preparation of a clinical solution of rituximab 1.0 mg/mL on the particulates (aggregation) measured by dynamic light scattering: sodium chloride and … N Natalia-Iglesias, J Hermosilla, J Exposito, A Salmerón-Garcia, ... European Journal of Hospital Pharmacy 27 (Suppl 1), A43-A43, 2020 | | 2020 |
| Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes NA Navas Iglesias, J Hermosilla, A Torrente López, J Hernández Jiménez, ... ELSEVIER, 2020 | | 2020 |
